NASDAQ:PHAR | News — Page 2 | Pharming Group N.V.

PHAR News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2021-05-17Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-05-13Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-04-22Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-04-07Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-04-07Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-03-23Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-03-16Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-03-11Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-03-04Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2021-03-02Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.
2020-12-23Foreign issuer reportSEC filingPharming Group N.V. filed Form 6-KPharming Group N.V. filed Form 6-K.